Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)

CNY 32.67

(0.28%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.57 Billion 2.75 Billion 2.43 Billion 633.91 Million 210.44 Million 154.63 Million
Total Current Assets 2.08 Billion 2.23 Billion 2.03 Billion 467.98 Million 98.35 Million 85.67 Million
Cash And Short Term Investments 1.9 Billion 2.04 Billion 1.72 Billion 261.17 Million 13.8 Million 16.33 Million
Cash and Cash Equivalents 1.9 Billion 1.93 Billion 1.36 Billion 261.17 Million 13.8 Million 16.33 Million
Short Term Investments 3.73 Billion 100.06 Million 360.84 Million - - -
Net Receivables 65.99 Million 44.85 Million 161.82 Million 110.52 Million 47.17 Million 34.07 Million
Inventory 99.32 Million 135.19 Million 141.7 Million 92.38 Million 36.38 Million 34.78 Million
Other Current Assets 14.06 Million 15.17 Million 600.64 Thousand 3.9 Million 983.9 Thousand 469.49 Thousand
Total Non-Current Assets 492.76 Million 515.94 Million 398.79 Million 165.92 Million 112.09 Million 68.96 Million
Net PPE 261.57 Million 244.67 Million 231.01 Million 138.65 Million 88.83 Million 43.72 Million
Good Will And Intangible Assets 208.7 Million 213.7 Million 20.34 Million 20.74 Million 21.32 Million 21.57 Million
Good Will - - - - - -
Intangible Assets 208.7 Million 213.7 Million 20.34 Million 20.74 Million 21.32 Million 21.57 Million
Long-Term Investments -3.72 Billion 4.19 Million 3.09 Million 398.95 Thousand 1.00 -
Tax Assets 14.44 Million 12.8 Million 3 Million 1.52 Million 1.09 Million 999.83 Thousand
Other Non Current Assets 3.73 Billion 40.56 Million 141.33 Million 4.61 Million 836.5 Thousand 2.66 Million
Other Assets 1.00 1.00 1.00 - - 1.00
Total Liabilities 158.82 Million 188.92 Million 323.35 Million 190.89 Million 84.49 Million 56.48 Million
Total Current Liabilities 149.42 Million 171.07 Million 317.56 Million 190.58 Million 72 Million 55.84 Million
Account Payables 58.35 Million 88.72 Million 224.32 Million 110.89 Million 42.74 Million 28.04 Million
Tax Payables 3.13 Million 9.57 Million 41.15 Million 45.54 Million 412.54 Thousand 565.28 Thousand
Short Term Debt 3.03 Million 5.45 Million 7.92 Million 11.08 Million 20.11 Million 20.09 Million
Deferred Revenue 87.52 Million 44.68 Million 85.14 Million 68.4 Million 5.75 Million 565.28 Thousand
Other Current Liabilities 506.25 Thousand 32.22 Million 171.55 Thousand 188.6 Thousand 3.39 Million 7.14 Million
Total Non Current Liabilities 9.39 Million 17.84 Million 5.79 Million 310.56 Thousand 12.48 Million 632.68 Thousand
Long-Term Debt - 2.19 Million 4.54 Million 6.99 Million 12.01 Million -
Deferred Revenue Non Current 8.68 Million 6.42 Million 1.24 Million 310.56 Thousand 471.62 Thousand 632.68 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 8.42 Million 1.24 Million -6.99 Million -12.01 Million -
Other Liabilities - 1.00 1.00 - 1.00 -
Total Equity 2.42 Billion 2.56 Billion 2.1 Billion 443.02 Million 125.94 Million 98.15 Million
Stock Holders Equity 2.41 Billion 2.56 Billion 2.1 Billion 444.13 Million 126.96 Million 98.85 Million
Common Stock 106.66 Million 106.66 Million 106.66 Million 80 Million 80 Million 80 Million
Retained Earnings 1.45 Billion 1.58 Billion 1.13 Billion 311.2 Million 28.58 Million 3.76 Million
Accumulated other comprehensive income 2.41 Billion 54.54 Million 54.03 Million 52.93 Million 18.37 Million 15.09 Million
Common Stock Equity 2.41 Billion 2.56 Billion 2.1 Billion 444.13 Million 126.96 Million 98.85 Million
Capital Lease Obligation 2.45 Million 2.19 Million 4.54 Million 6.99 Million - -
Total Investments 2.84 Million 100.06 Million 360.84 Million 398.95 Thousand 1.00 -
Total Debt 3.03 Million 7.64 Million 12.47 Million 11.08 Million 32.12 Million 20.09 Million
Net Debt -1.9 Billion -1.93 Billion -1.35 Billion -250.08 Million 18.32 Million 3.75 Million

Balance Sheet Charts